Psychedelic Clinical Trials with Dr. Randy Brown

Caffeinate & Innovate: Psychedelic Clinical Trials with Dr. Randy Brown

It's time to Caffeinate & Innovate again April 15 at 9AM CST! We're welcoming Dr. Randall Brown to discuss new research and clinical trials of psychedelics.

Brown is widely recognized as one of the nation’s leading voices in addiction medicine research. He has served as a principal investigator on psychedelic clinical trials for more than a decade and was first author on seminal University of Wisconsin work related to psilocybin pharmacology. He also served as site co‑principal investigator on major multisite studies of psilocybin for depressive disorder and MDMA for post‑traumatic stress disorder, with results published in JAMA Psychiatry and Nature Medicine.

Learn more and register

For trainings that indicate Continuing Education Units (CEUs) are available, contact your licensing or certification organization to verify that the credits will count toward the continuing education requirements.